Effect of Zizyphus Jujuba and Cotoneaster on Neonatal Jaundice
Phase 1
Completed
- Conditions
- eonatal jaundice.Neonatal jaundice from other and unspecified causes
- Registration Number
- IRCT20180421039375N2
- Lead Sponsor
- Ahvaz University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 90
Inclusion Criteria
Term and healthy baby
2 to 14 days old
indirect hyperbilirubinemia
Exclusion Criteria
Preterm newborn
Bilirubin is more than 25 and subjected to blood exchange
Sensitivity to Cotonester and Zizyphus Jujube
Create major curative complication
Parental dissatisfaction with participation in the study
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method eonatal jaundice in newborns with bilirubin 15-22. Timepoint: Before the onset of intervention and 12, 24, 36, 48 hours after the intervention. Method of measurement: questionnaire.
- Secondary Outcome Measures
Name Time Method Infant Nutrition. Timepoint: Beginning and after yellowing. Method of measurement: Questionnaire with 10 questions.
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie Zizyphus Jujuba and Cotoneaster's efficacy in neonatal jaundice?
How do Zizyphus Jujuba and Cotoneaster compare to phototherapy in treating neonatal hyperbilirubinemia?
Are there specific bilirubin metabolism biomarkers that predict response to Zizyphus Jujuba and Cotoneaster treatment?
What adverse events are associated with Zizyphus Jujuba and Cotoneaster in neonatal populations?
What other phytochemical compounds show promise in neonatal jaundice treatment alongside Zizyphus Jujuba and Cotoneaster?